Showing 40,101 - 40,120 results of 134,670 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.42s Refine Results
  1. 40101

    DataSheet1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.docx by Zehua Zhang (312656)

    Published 2022
    “…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”
  2. 40102
  3. 40103

    Tra2β protein levels are drastically reduced in the brains of neuronal specific <i>Sfrs10</i> knockout mice and correlate with defects in splicing of the <i>Nasp-T</i> cassette and... by Sushma Grellscheid (191887)

    Published 2011
    “…<p>(A) Whole brain sections derived from 16.5 dpc <i>Sfrs10</i><sup>fl/wt</sup>; Nestin-Cre<sup>tg</sup> (left panel) and <i>Sfrs10</i><sup>fl/fl</sup>; Nestin-Cre<sup>tg</sup> (right panel) stained with antibodies against Tra2β. …”
  4. 40104

    Discovery and Development of <i>N</i>‑[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Act... by Ramakrishna Nirogi (2025910)

    Published 2019
    “…A series of chemical optimizations guided by in vitro affinity at a histamine H<sub>3</sub> receptor (H<sub>3</sub>R), physicochemical properties, and pharmacokinetics in rats resulted in identification of <i>N</i>-[4-(1-cyclobutyl-piperidin-4-yloxy)­phenyl]-2-(morpholin-4-yl)­acetamide dihydrochloride (<b>17v</b>, SUVN-G3031) as a clinical candidate. …”
  5. 40105

    Presentation_1_Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells.PDF by Alejandro Sánchez-Melgar (3950141)

    Published 2021
    “…Adenosine activates specific G-protein coupled receptors named A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> receptors. …”
  6. 40106

    Reduced MMP2 activity in Antxr2 deficient tissue and cells. by Claire V. Reeves (172057)

    Published 2012
    “…(C) Conditioned medium from HUVEC cell lines with knock down of ANTXR2 expression (shANTXR2 HUVEC) had reduced MMP2 activity as determined by gelatin zymography. …”
  7. 40107
  8. 40108
  9. 40109
  10. 40110
  11. 40111

    Kinetic and Mechanistic Studies on the Reaction of Nitric Oxide with a Water-Soluble Octa-anionic Iron(III) Porphyrin Complex by Joo-Eun Jee (1973230)

    Published 2005
    “…The rate constant <i>k</i><sub>on</sub> = 6.2 × 10<sup>4</sup> M<sup>-1</sup> s<sup>-1</sup> (24 °C), determined for NO binding to the monohydroxo-ligated (P<sup>8-</sup>)Fe<sup>III</sup>(OH) (<b>1-OH</b>) present in solution at pH >9, is markedly lower than the corresponding value measured for <b>1-H</b><b><sub>2</sub></b><b>O</b> at lower pH (<i>k</i><sub>on</sub> = 8.2 × 10<sup>5</sup> M<sup>-1</sup> s<sup>-1</sup>, 24 °C, pH 7). …”
  12. 40112
  13. 40113
  14. 40114
  15. 40115
  16. 40116
  17. 40117
  18. 40118

    Waterborne exposure to BPS causes thyroid endocrine disruption in zebrafish larvae by Dan-hua Zhang (3997844)

    Published 2017
    “…After exposure to BPS, the mRNA expression of corticotrophin releasing hormone (<i>crh</i>) and thyroglobulin (<i>tg</i>) genes were up-regulated at ≥10 μg/L of BPS, in a dose-response manner. The transcription of genes involved in thyroid development (<i>pax8</i>) and synthesis (sodium/iodide symporter, <i>slc5a5</i>) were also significantly increased in the 30 μg/L of BPS treatment group. …”
  19. 40119

    Summary of previous work. by Junyan Wang (4738518)

    Published 2025
    “…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. …”
  20. 40120

    YOLO11. by Junyan Wang (4738518)

    Published 2025
    “…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. …”